Clinical snapshot — for veterinary teams
- Active ingredient / class: trilostane — reversible inhibitor of 3β-hydroxysteroid dehydrogenase (blocks cortisol synthesis); FDA-approved as Vetoryl for canine pituitary- and adrenal-dependent Cushing’s (hyperadrenocorticism)
- Nature of therapy: manages, doesn’t cure; given with food, started at the lowest practical dose; cortisol most suppressed 3–8 hours post-dose
- ⚠️ The defining risk: iatrogenic hypoadrenocorticism (Addisonian crisis) — can occur at any dose and develop suddenly. Signs (reduced appetite, vomiting, diarrhea, lethargy, weakness, collapse) mean the owner should stop Vetoryl and contact the vet immediately — these are not side effects to “ride out”
- Monitoring schedule: recheck (history, exam, serum chemistry + electrolytes, ACTH stimulation test performed 4–6 hours post-dose, or pre-pill cortisol) at 10–14 days, after any dose change, then 30 days, 90 days, and every 3 months; don’t increase dose before 30 days
- Counsel clients on: the stop-and-call signs above; goal is controlling PU/PD, panting, appetite, and coat
- Contraindicated: hepatic or renal disease, pregnancy; never give to a hospitalized/ill dog
Plain answer for owners who landed here: Vetoryl (trilostane) treats Cushing’s disease in dogs by lowering cortisol. It manages the disease rather than curing it, is given with food, and needs careful, scheduled bloodwork (around 10–14 days after starting or any dose change, then 30 days, 90 days, and every 3 months). The single most important thing: if your dog becomes lethargic, off food, or starts vomiting or having diarrhea, stop the medication and call your vet right away — these can mean cortisol has dropped too low, which is dangerous. Don’t treat those signs as “normal side effects to wait out.”
What it’s used for — and why follow-up is the whole game
Cushing’s treatment is a balancing act: trilostane has to bring cortisol down enough to relieve signs (excess thirst, urination, hunger, panting, coat changes) without pushing it too low into an Addisonian crisis. Because over-suppression can happen at any dose and come on suddenly, the follow-up isn’t optional housekeeping — it’s the core safety mechanism. Two things define it: an owner who knows the stop-and-call signs, and a timed recheck cadence with ACTH-stim or pre-pill cortisol testing. Get either wrong and a manageable disease becomes an emergency. Few drugs make structured follow-up this load-bearing.
The adverse-event and monitoring profile
Per the FDA-approved labeling and veterinary references, the common effects — reduced appetite, vomiting, diarrhea, lethargy, weakness — are exactly the signs of cortisol dropping too low, which is why they warrant stopping the drug and calling rather than waiting. Iatrogenic hypoadrenocorticism can develop at any dose, sometimes with electrolyte changes (hyperkalemia, hyponatremia). Monitoring uses clinical signs plus serum chemistry/electrolytes and an ACTH stimulation test (performed 4–6 hours after dosing, the peak-suppression window) — or, increasingly, a pre-pill cortisol paired with an owner diary — at 10–14 days, after dose changes, then 30 days, 90 days, and quarterly. It’s contraindicated in hepatic/renal disease and pregnancy, and shouldn’t be started in an unwell dog. (Sources: Vetoryl (trilostane) labeling via Drugs.com; AAHA monitoring guidance; dvm360 Cushing’s management.)
The follow-up window that matters
Three layers. Continuously, the owner must watch for stop-and-call signs (this never ends). At 10–14 days and after every dose change, the timed recheck confirms the dog isn’t over-suppressed. And at 30/90 days then quarterly, monitoring keeps control dialed in — under-treatment leaves Cushing’s signs, over-treatment risks crisis.
What to ask clients at follow-up
A safety-first check:
- Is your dog eating normally and energetic — any vomiting, diarrhea, lethargy, weakness, or drop in appetite/thirst? (if yes → stop and call)
- Are the Cushing’s signs improving (less drinking, urinating, panting, hunger)?
- Are you giving it with food, consistently, and not increasing the dose on your own?
- Is the next recheck/ACTH-stim booked — and do you know it’s timed a few hours after the dose?
The first question is potentially life-saving; the recheck-timing question protects test accuracy and dosing safety.
Where compliance breaks down
Two dangerous failures. Owners misread over-suppression as ordinary side effects and keep dosing instead of stopping. And the timed recheck cadence slips — testing is costly and easy to defer, so over- or under-control goes undetected. Both are follow-up gaps, and both can be serious on this drug.
Standardizing this follow-up without adding staff time
This is an exceptional fit for Nidana Loop. For a trilostane patient, Loop calls or texts the owner to screen specifically for the stop-and-call signs (appetite, GI, energy) and reinforce the instruction to halt the drug and call if they appear, tracks the Cushing’s signs at home (the diary that improves monitoring), and prompts the timed 10–14-day, 30-day, 90-day, and quarterly rechecks — returning it all as a structured note and flagging any over-suppression signal to a vet urgently. The safety mechanism that trilostane depends on becomes something the clinic actively runs, with no staff calls.
See Loop handle medication follow-up
Loop runs your hypocortisolism stop-and-call screen, home sign tracking, and timed recheck reminders automatically — returning structured outcomes to the clinic. Book a 20-minute demo → · See how Loop works →
For pet owners
What’s the most important thing to watch for? Lethargy, loss of appetite, vomiting, diarrhea, or weakness — stop the medication and call your vet right away, as these can mean cortisol has dropped too low.
Why so much bloodwork? To keep the dose in the safe zone — testing is done about 10–14 days after starting or any change, then 30 days, 90 days, and every 3 months, usually a few hours after the dose.
Does it cure Cushing’s? No — it manages the disease; signs return if it’s stopped.
How is it given? With food, as prescribed; don’t increase the dose on your own.
This article is general information, not veterinary advice. Owners should consult their veterinarian and follow the product’s FDA-approved label.
Sources: Vetoryl (trilostane) labeling via Drugs.com; Monitoring trilostane therapy — AAHA; How to manage Cushing’s syndrome — dvm360.